← Browse by Condition
Medical Condition

metabolic dysfunction associated steatotic liver disease masld

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05648214 Phase 1
Recruiting

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Enrollment
156 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →